893 results on '"Batista, Alzir A."'
Search Results
2. A novel ruthenium complex with 5-fluorouracil suppresses colorectal cancer stem cells by inhibiting Akt/mTOR signaling
3. Ruthenium complex containing 1,3-thiazolidine-2-thione inhibits hepatic cancer stem cells by suppressing Akt/mTOR signalling and leading to apoptotic and autophagic cell death
4. New Ru(II)-p-cymene compounds bearing indomethacin and indomethacin-pyridineamide ligands: synthesis, characterization, computational studies and investigation of their interactions with the Human Serum Albumin
5. Phenanthroline and phenyl carboxylate mixed ligand copper complexes in developing drugs to treat cancer
6. Ru(II)-based complexes containing 2-thiouracil derivatives suppress liver cancer stem cells by targeting NF-κB and Akt/mTOR signaling
7. Cobalt(III)-py2en systems as potential carriers of β-ketoester-based ligands
8. An overview on the anticancer activity of Ru(II)/acylthiourea complexes
9. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos = bis-[(2-diphenylphosphino)phenyl]ether)
10. Molecular structure of Ru(II)/diphosphine/4,6-dimethyl-2-pyrimidinethiol complexes: A combined experimental and density functional theory study
11. Gallium and indium complexes with isoniazid-derived ligands: Interaction with biomolecules and biological activity against cancer cells and Mycobacterium tuberculosis
12. Tetramethyl-phenanthroline copper complexes in the development of drugs to treat cancer: synthesis, characterization and cytotoxicity studies of a series of copper(II)-l-dipeptide-3,4,7,8-tetramethyl-phenanthroline complexes
13. New ruthenium complexes containing salicylic acid and derivatives induce triple-negative tumor cell death via the intrinsic apoptotic pathway
14. Novel Ru(II)-bipyridine/phenanthroline-lapachol complexes as potential anti-cancer agents
15. cis and transisomers of Ru(III)-based complexes with lapachol: X-ray diffractions and DFT theoretical insights
16. Cytotoxic and antiparasitic activities of diphosphine-metal complexes of group 10 containing acylthiourea as ligands
17. Gold(III) heteroleptic complexes with SNS-thiosemicarbazonate ligands as cytotoxic agents: Experimental and computational insights into the mechanism of action
18. Ru(II)/amino acid complexes inhibit the progression of breast cancer cells through multiple mechanism-induced apoptosis
19. Antitumor Activity of New Pd(II) Complexes with Ligands Derived from O‐Vanillin Acting as Topoisomerase I and II Inhibitors.
20. Exploring the BSA- and DNA-binding, cytotoxicity, and cell cycle evaluation of ternary copper(II)/diimine complexes with N,N-dibenzyl-N′-benzoylthiourea as promising metallodrug candidates.
21. Exploring the potential of ruthenium(II)–phosphine–mercapto complexes as new anticancer agents.
22. Exploring the BSA-, DNA-binding, cytotoxicity and cell cycle evaluation of ternary copper(II)/diimine complexes with N,N-dibenzyl-N’-benzoylthiourea as promising metallodrug candidates
23. New Ru(Ii)-P-Cymene Compounds Bearing Indomethacin and Indomethacin-Pyridineamide Ligands: Synthesis, Characterization, Computational Studies and Investigation of Their Interactions with the Human Serum Albumin
24. Anti-melanoma effect of ruthenium(II)-diphosphine complexes containing naphthoquinone ligand
25. Scavenging capacity and cytotoxicity of new Ru(II)-diphosphine/α-amino acid complexes
26. Ruthenium (II)/allopurinol complex inhibits breast cancer progression via multiple targets
27. Ruthenium complexes show promise when submitted to toxicological safety tests using alternative methodologies
28. Lapachol in the Design of a New Ruthenium(II)-Diphosphine Complex as a Promising Anticancer Metallodrug
29. Synthesis and characterization of η6-p-cymene ruthenium(II) complexes containing alkyl- and methoxy-substituted triarylphosphines
30. Cytotoxicity of ruthenium-N,N-disubstituted-N′-acylthioureas complexes
31. Raman Spectroscopy on Free-Base Meso-tetra(4-pyridyl) Porphyrin under Conditions of Low Temperature and High Hydrostatic Pressure.
32. cis and trans isomers of Ru(III)-based complexes with lapachol: X-ray diffractions and DFT theoretical insights.
33. NAPROXEN/LAYERED DOUBLE HYDROXIDE COMPOSITES FOR TISSUE-ENGINEERING APPLICATIONS: PHYSICOCHEMICAL CHARACTERIZATION AND BIOLOGICAL EVALUATION
34. Ruthenium(II)/Benzonitrile Complex Induces Cytotoxic Effect in Sarcoma-180 Cells by Caspase-Mediated and Tp53/p21-Mediated Apoptosis, with Moderate Brine Shrimp Toxicity
35. Antitumor activity of Pd(II) complexes with N,S or O,S coordination modes of acylthiourea ligands
36. Evaluation of the biological potential of ruthenium(II) complexes with cinnamic acid
37. Synthesis and structural characterization of a series of ternary copper(II)-L-dipeptide-neocuproine complexes. Study of their cytotoxicity against cancer cells including MDA-MB-231, triple negative breast cancer cells
38. Structural and Anticancer Studies of Methoxyflavone Derivative from Strychnos pseudoquina A.St.-Hil. (Loganiaceae) from Brazilian Cerrado
39. Synthesis, Characterization, DNA Binding and Cytotoxicity of Copper(II) Phenylcarboxylate Complexes
40. Ru(II)-Based Amino Acid Complexes Show Promise for Leukemia Treatment: Cytotoxicity and Some Light on their Mechanism of Action
41. cis-bis(N-benzoyl-N′,N′-dibenzylthioureido)platinum(II): Synthesis, molecular structure and its interaction with human and bovine serum albumin
42. Ru(II) complexes containing uracil nucleobase analogs with cytotoxicity against tumor cells
43. A simple alternative to prodrug: The hydrochloride salt monohydrate of the prostate anticancer drug abiraterone
44. Ru(II)/N-N/PPh3 complexes as potential anticancer agents against MDA-MB-231 cancer cells (N-N = diimine or diamine)
45. Acute toxic effects of ruthenium (II)/amino acid/diphosphine complexes on Swiss mice and zebrafish embryos
46. Hydrolysis reaction promotes changes in coordination mode of Ru(II)/acylthiourea organometallic complexes with cytotoxicity against human lung tumor cell lines
47. The trans-[Ru(PPh3)2(N,N-dimethyl-N′-thiophenylthioureato-k2O,S)(bipy)]PF6 complex has pro-apoptotic effects on triple negative breast cancer cells and presents low toxicity in vivo
48. Cover Feature: Antimalarial Agents Derived from Metal‐Amodiaquine Complexes with Activity in Multiple Stages of the Plasmodium Life Cycle (Chem. Eur. J. 55/2023)
49. Cytotoxic activity of Ru(II)/DPEPhos/N,S-mercapto complexes (DPEPhos -[(2-diphenylphosphino)phenyl]ether)
50. Nanoencapsulation of Ruthenium Complex Ru(ThySMet): A Strategy to Improve Selective Cytotoxicity Against Breast Tumor Cells in 2D and 3D Culture Models
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.